Search

Stradling

Sonus Pharmaceuticals, Inc. Completes Merger With OncoGenex Technologies, Inc.

Sonus Pharmaceuticals, Inc.

Represented Sonus Pharmaceuticals, Inc. (Nasdaq: SNUS) in its merger with OncoGenex Technologies, Inc. to become OncoGenex Pharmaceuticals.

OncoGenex is a biopharmaceutical company focused on cancer treatment resistance, with locations in Washington and British Columbia.